Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challenge

Frontiers in Oncology

Oncology

Benedetta Renzetti¹  Cristina De Fino¹  Riccardo Schiavina²  Eugenio Brunocilla²  Lorenzo Bianchi²  Matteo Droghetti²  Michelangelo Fiorentino³  Francesca Giunchi⁴  Caterina Gaudiano⁵  Beniamino Corcioni⁵  Federica Ciccarese⁵ 

[1] Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy;Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy;Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy;Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy;Department of Pathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy;Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy;

关键词: prostate cancer;    granulomatous prostatitis;    non-specific granulomatous prostatitis;    granulomatous prostatitis induced by BCG;    multiparametric magnetic resonance imaging;    PI-RADS score;   

DOI  :  10.3389/fonc.2023.1178430

 received in 2023-03-02, accepted in 2023-05-22,  发布年份 2023

来源: Frontiers

【 摘 要 】

Multiparametric magnetic resonance imaging (mpMRI) is currently the most effective diagnostic tool for detecting prostate cancer (PCa) and evaluating adenocarcinoma-mimicking lesions of the prostate gland, among which granulomatous prostatitis (GP) represents the most interesting diagnostic challenge. GP consists of a heterogeneous group of chronic inflammatory lesions that can be differentiated into four types: idiopathic, infective, iatrogenic, and associated with systemic granulomatous disease. The incidence of GP is growing due to the increase in endourological surgical interventions and the adoption of intravesical instillation of Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer; therefore, the difficulty lies in identifying specific features of GP on mpMRI to avoid the use of transrectal prostate biopsy as much as possible.

【 授权许可】

Unknown   
Copyright © 2023 Gaudiano, Renzetti, De Fino, Corcioni, Ciccarese, Bianchi, Schiavina, Droghetti, Giunchi, Brunocilla and Fiorentino